Achilles Therapeutics

NASDAQ: ACHL · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM

Achilles Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.51 -0.49 -2.35
PEG Ratio
0.12 0.03 -0.01
PS Ratio
n/a n/a n/a
PB Ratio
0.25 0.18 0.50
P/FCF Ratio
-0.72 -0.53 -2.15
P/OCF Ratio
-0.73 -0.59 -2.42
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
0.03 0.04 0.04
Quick Ratio
8.57 10.67 14.63
Current Ratio
8.57 10.93 14.90
Asset Turnover
n/a n/a n/a
Interest Coverage
n/a n/a n/a
Return on Equity
-0.49 -0.36 -0.21
Return on Assets
-0.43 -0.32 -0.19
Return on Invested Capital
-0.51 -0.38 -0.21
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a